Groundbreaking Vitamin K2 Research Presented at the 7^th Osteoporosis Congress in Padova (March 19-21, 2025)

April 9, 2025

MenaQ7®• Mobility & Joint• News• Vitamin K2• Wellness & Immune

Share this article:

Gnosis by Lesaffre recently took an important step in advancing the scientific understanding of vitamin K2 by sponsoring the 7^th Osteoporosis Congress in Padova, Italy. Supported by the Italian Ministry of Health, this event brought together esteemed experts in nephrology, osteoporosis, and bone health.

The congress was chaired by Dr. Maria Fusaro, a renowned medical doctor and researcher known for her extensive work on vitamin K. During the event, Dr. Fusaro emphasized the critical role of vitamin K2, specifically MenaQ7^®, in supporting bone health.

We are excited to have participated in this prestigious event. Our sponsorship of the 7^th Osteoporosis Congress underscores our commitment to advancing the scientific understanding of vitamin K2 and its importance for overall health.

A key highlight of the congress was Dr. Fusaro’s announcement regarding a long-term project focused on identifying the most effective forms of vitamin K among the available molecules. This initiative aims to shed light on the effectiveness and potential applications of different variants of vitamin K.

Additionally, the congress highlighted a significant interest among attending physicians in gaining more knowledge about vitamin K2. Many doctors were not fully informed about this particular nutrient but showed a strong desire to learn about its significance and potential advantages.

The doctors’ excitement and inquisitiveness at the event were incredibly inspiring. This underscores the necessity for ongoing education and research in vitamin K2, and we look forward to exploring potential collaborations with Dr. Fusaro and other prominent experts in this field.

Gnosis’s involvement in the 7^th Osteoporosis Congress reflects its commitment to enhancing awareness and understanding of vitamin K2 among both healthcare professionals and the general public. Gnosis is dedicated to promoting bone health and overall wellness by sponsoring these events and supporting innovative research initiatives.

Download our MenaQ7^® brochure to discover more!

Ingredients mentioned

MenaQ7®

Active ingredients

Vitamin K2: MenaQ7^® is the optimal bioavailable 99.8% all-trans vitamin K2 as MK-7, produced in the only European plant manufacturing K2 by natural fermentation under the highest quality standards and sustainability measures.

Mobility & Joint
Wellness & Immune
Reproduction & Women’s

Bone
Cardiovascular
Menopause

MenaQ7® Palm-Free MCT Oil

Active ingredients

Vitamin K2 : for oil-based, sustainable, and palm-free finished product formulations, MenaQ7^® Palm-Free MCT Oil combines natural fermentation's purest all-trans vitamin K2, the clinically proven health benefits of MenaQ7^®, and a 100% organic coconut oil carrier. Produced in Europe in Gnosis GMP certified plant.

Mobility & Joint
Wellness & Immune
Reproduction & Women’s

Bone
Cardiovascular
Menopause

MenaQ7® Matrix

Active ingredients

Vitamin K2 : The clinically proven health benefits of MenaQ7^® delivered via an award-winning Vitamin K2 Matrix protective technology. Formulate even under the harshest conditions of supplement & food processing with MenaQ7^® Matrix, the natural choice for stable and protected Vitamin K2, without coating, nor additives.

Mobility & Joint
Wellness & Immune
Reproduction & Women’s

Bone
Cardiovascular
Menopause

Groundbreaking Vitamin K2 Research Presented at the 7^th Osteoporosis Congress in Padova (March 19-21, 2025)